19.65
0.64 (3.37%)
| Previous Close | 19.01 |
| Open | 19.09 |
| Volume | 94,450 |
| Avg. Volume (3M) | 190,629 |
| Market Cap | 333,399,968 |
| Price / Sales | 0.300 |
| Price / Book | 43.86 |
| 52 Weeks Range | |
| Earnings Date | 7 May 2026 |
| Profit Margin | -126.96% |
| Operating Margin (TTM) | 4.21% |
| Diluted EPS (TTM) | -72.90 |
| Quarterly Revenue Growth (YOY) | -1.40% |
| Total Debt/Equity (MRQ) | 31,271.65% |
| Current Ratio (MRQ) | 1.02 |
| Operating Cash Flow (TTM) | 27.84 M |
| Levered Free Cash Flow (TTM) | 140.38 M |
| Return on Assets (TTM) | 0.83% |
| Return on Equity (TTM) | -198.69% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Claritev Corporation | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | 2.0 |
| Average | 1.75 |
|
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 7.81% |
| % Held by Institutions | 82.25% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| H&F Corporate Investors Viii, Ltd. | 31 Dec 2025 | 3,887,858 |
| Arini Captial Management Ltd | 31 Dec 2025 | 1,503,892 |
| Public Investment Fund | 31 Dec 2025 | 1,281,250 |
| Beach Point Capital Management Lp | 31 Dec 2025 | 755,002 |
| Cpv Partners, Llc | 31 Dec 2025 | 495,258 |
| Caspian Capital Lp | 31 Dec 2025 | 250,000 |
| Topline Capital Management, Llc | 31 Dec 2025 | 196,718 |
| Third Point Llc | 31 Dec 2025 | 145,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 38.00 (Guggenheim, 93.38%) | Buy |
| Median | 30.00 (52.67%) | |
| Low | 21.00 (Citigroup, 6.87%) | Buy |
| Average | 29.67 (50.99%) | |
| Total | 2 Buy, 1 Hold | |
| Avg. Price @ Call | 13.99 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 25 Feb 2026 | 21.00 (6.87%) | Buy | 14.82 |
| Guggenheim | 24 Feb 2026 | 38.00 (93.38%) | Buy | 13.57 |
| Wells Fargo | 24 Feb 2026 | 30.00 (52.67%) | Hold | 13.57 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 29 Jan 2026 | Announcement | Claritev Corporation Announces Fourth Quarter 2025 Earnings Conference Call |
| 21 Jan 2026 | Announcement | Claritev and Kinetiq Health Enter Into Strategic Agreement to Strengthen Cost Management and Advance Claims Surveillance and Diagnostic Certainty |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |